Dr. Saif has been recognized as an internationally renowned expert and Key Opinion Leader (KOL) in the fields of Gastrointestinal (GI) cancers, Experimental Therapeutics and Pharmacogenetics as well as an exemplary clinician. He has been involved in the development and management of clinical trials with focus on translational research, standardization of treatment algorithms, collaboration among different modalities, mentorship of junior staff and training physicians and medical students for the last two decades.
His major contributions include: Contributions to Science
The Barbara Ann Karmanos Cancer Institute welcomes Wasif Saif, M.D., MBBS , as the new leader of the Phase I Clinical Trials Multidisciplinary Team and co-leader of the Gastrointestinal (GI) and Neuroendocrine Oncology Multidisciplinary Team (MDT). Dr. Saif is a world-renowned hematologist and oncologist specializing in GI cancers, experimental therapeutics and pharmacogenetics. He joined Karmanos on March 1, 2024. “Karmanos Cancer Institute is a trailblazer in cancer research and has been a m...